Elsewhere the issue of Synlait / Dunsandel holding the SAMR registration for China Label Infant formula.
Synlait today announced that in the absence of a loan then the may face closure or liquidation.
This would seem to be a material risk to A2, if there was going to be a disruption of the supply of China Label IF. But A2 have been silent - no market updates on that risk.
So perhaps they don't see a material risk at all and they have mitigating processes in play.
Synlait, page-96
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B | |||
| Open | High | Low | Value | Volume |
| $4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10795 | $4.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.83 | 5662 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |